Stay updated on Pembrolizumab in Advanced Head and Neck Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.

Latest updates to the Pembrolizumab in Advanced Head and Neck Clinical Trial page
- CheckyesterdayChange DetectedA funding attribution for 2017 NIH grant/contract has been added to the study details, indicating NIH support for the trial.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedA new revision tag v3.6.5 was added to the page, and the Plain Language Summary section was removed along with the previous revision tag v3.6.4, indicating a versioning update that alters the accessible summary content.SummaryDifference0.0%

- Check23 days agoChange DetectedNew update dates were added to the study's update history: 2026-07-31, 2026-07-29, and 2026-07, and older dates were removed (2026-07-27, 2026-07-08, 2026-06). These changes reflect recent posting activity and maintenance of the page's update timeline.SummaryDifference0.1%

- Check30 days agoChange DetectedAdded Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Universitaire (Site 0209) and Gliwice, Silesian Voivodeship, Poland (44-102) to the locations, while removing the previous CIUSSS de l'Estrie-CHUS entry (Site 0209) and Gliwice 44-101. Renamed/standardized the Charing Cross Hospital site (Site 1603) to reflect the official institutional naming.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page revision was updated from v3.6.2 to v3.6.3, representing a new patch release. No user-facing content changes are described.SummaryDifference0.0%

- Check60 days agoChange DetectedThe page now displays Revision: v3.6.2, replacing the previous Revision: v3.6.0. This indicates a recent deployment update to the site's software or content management system.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Advanced Head and Neck Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Advanced Head and Neck Clinical Trial page.